Isomorphic Labs announced a new Series B investment round to fund its AI-first drug discovery platform. The round supports continued development of the company’s Unified Drug Design Engine and its therapeutic pipeline.
Need help?
Contact usIsomorphic Labs announced a new Series B investment round to fund its AI-first drug discovery platform. The round supports continued development of the company’s Unified Drug Design Engine and its therapeutic pipeline.